Home > > > Report Detail

Global Non-Invasive Prenatal Testing Market 2020 by Company, Regions, Type and Application, Forecast to 2025

Publisher Name :
Date: 22-Feb-2020
No. of pages: 102

Market Overview

The global Non-Invasive Prenatal Testing market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Non-Invasive Prenatal Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation

Non-Invasive Prenatal Testing market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Non-Invasive Prenatal Testing market has been segmented into:

- High & Average Risk

- Low Risk

By Application, Non-Invasive Prenatal Testing has been segmented into:

- 0-12 weeks

- 13-24 weeks

- 25-36 weeks

Regions and Countries Level Analysis

Regional analysis is another highly comprehensive part of the research and analysis study of the global Non-Invasive Prenatal Testing market presented in the report. This section sheds light on the sales growth of different regional and country-level Non-Invasive Prenatal Testing markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Non-Invasive Prenatal Testing market.

The report offers in-depth assessment of the growth and other aspects of the Non-Invasive Prenatal Testing market in important countries (regions), including:

- North America (United States, Canada and Mexico)

- Europe (Germany, France, UK, Russia and Italy)

- Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)

- South America (Brazil, Argentina, Colombia)

- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Non-Invasive Prenatal Testing Market Share Analysis

Non-Invasive Prenatal Testing competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Non-Invasive Prenatal Testing sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Non-Invasive Prenatal Testing sales, revenue and market share for each player covered in this report.

The major players covered in Non-Invasive Prenatal Testing are:

Sequenom

Berry Genomics

LabCorp

Roche

Illumina

Natera

Quest Diagnostics

BGI Genomics

Global Non-Invasive Prenatal Testing Market 2020 by Company, Regions, Type and Application, Forecast to 2025

Table of Contents

1 Non-Invasive Prenatal Testing Market Overview
1.1 Product Overview and Scope of Non-Invasive Prenatal Testing
1.2 Classification of Non-Invasive Prenatal Testing by Type
1.2.1 Global Non-Invasive Prenatal Testing Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Non-Invasive Prenatal Testing Revenue Market Share by Type in 2019
1.2.3 High & Average Risk
1.2.4 Low Risk
1.3 Global Non-Invasive Prenatal Testing Market by Application
1.3.1 Overview: Global Non-Invasive Prenatal Testing Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 0-12 weeks
1.3.3 13-24 weeks
1.3.4 25-36 weeks
1.4 Global Non-Invasive Prenatal Testing Market by Regions
1.4.1 Global Non-Invasive Prenatal Testing Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Non-Invasive Prenatal Testing (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Non-Invasive Prenatal Testing Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Non-Invasive Prenatal Testing Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Non-Invasive Prenatal Testing Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Non-Invasive Prenatal Testing Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Non-Invasive Prenatal Testing Status and Prospect (2015-2025)
2 Company Profiles
2.1 Sequenom
2.1.1 Sequenom Details
2.1.2 Sequenom Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Sequenom SWOT Analysis
2.1.4 Sequenom Product and Services
2.1.5 Sequenom Non-Invasive Prenatal Testing Revenue, Gross Margin and Market Share (2018-2019)
2.2 Berry Genomics
2.2.1 Berry Genomics Details
2.2.2 Berry Genomics Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Berry Genomics SWOT Analysis
2.2.4 Berry Genomics Product and Services
2.2.5 Berry Genomics Non-Invasive Prenatal Testing Revenue, Gross Margin and Market Share (2018-2019)
2.3 LabCorp
2.3.1 LabCorp Details
2.3.2 LabCorp Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 LabCorp SWOT Analysis
2.3.4 LabCorp Product and Services
2.3.5 LabCorp Non-Invasive Prenatal Testing Revenue, Gross Margin and Market Share (2018-2019)
2.4 Roche
2.4.1 Roche Details
2.4.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Roche SWOT Analysis
2.4.4 Roche Product and Services
2.4.5 Roche Non-Invasive Prenatal Testing Revenue, Gross Margin and Market Share (2018-2019)
2.5 Illumina
2.5.1 Illumina Details
2.5.2 Illumina Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Illumina SWOT Analysis
2.5.4 Illumina Product and Services
2.5.5 Illumina Non-Invasive Prenatal Testing Revenue, Gross Margin and Market Share (2018-2019)
2.6 Natera
2.6.1 Natera Details
2.6.2 Natera Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Natera SWOT Analysis
2.6.4 Natera Product and Services
2.6.5 Natera Non-Invasive Prenatal Testing Revenue, Gross Margin and Market Share (2018-2019)
2.7 Quest Diagnostics
2.7.1 Quest Diagnostics Details
2.7.2 Quest Diagnostics Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Quest Diagnostics SWOT Analysis
2.7.4 Quest Diagnostics Product and Services
2.7.5 Quest Diagnostics Non-Invasive Prenatal Testing Revenue, Gross Margin and Market Share (2018-2019)
2.8 BGI Genomics
2.8.1 BGI Genomics Details
2.8.2 BGI Genomics Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 BGI Genomics SWOT Analysis
2.8.4 BGI Genomics Product and Services
2.8.5 BGI Genomics Non-Invasive Prenatal Testing Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Non-Invasive Prenatal Testing Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Non-Invasive Prenatal Testing Players Market Share
3.2.2 Top 10 Non-Invasive Prenatal Testing Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Non-Invasive Prenatal Testing Revenue and Market Share by Regions
4.2 North America Non-Invasive Prenatal Testing Revenue and Growth Rate (2015-2020)
4.3 Europe Non-Invasive Prenatal Testing Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Non-Invasive Prenatal Testing Revenue and Growth Rate (2015-2020)
4.5 South America Non-Invasive Prenatal Testing Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Non-Invasive Prenatal Testing Revenue and Growth Rate (2015-2020)
5 North America Non-Invasive Prenatal Testing Revenue by Countries
5.1 North America Non-Invasive Prenatal Testing Revenue by Countries (2015-2020)
5.2 USA Non-Invasive Prenatal Testing Revenue and Growth Rate (2015-2020)
5.3 Canada Non-Invasive Prenatal Testing Revenue and Growth Rate (2015-2020)
5.4 Mexico Non-Invasive Prenatal Testing Revenue and Growth Rate (2015-2020)
6 Europe Non-Invasive Prenatal Testing Revenue by Countries
6.1 Europe Non-Invasive Prenatal Testing Revenue by Countries (2015-2020)
6.2 Germany Non-Invasive Prenatal Testing Revenue and Growth Rate (2015-2020)
6.3 UK Non-Invasive Prenatal Testing Revenue and Growth Rate (2015-2020)
6.4 France Non-Invasive Prenatal Testing Revenue and Growth Rate (2015-2020)
6.5 Russia Non-Invasive Prenatal Testing Revenue and Growth Rate (2015-2020)
6.6 Italy Non-Invasive Prenatal Testing Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Non-Invasive Prenatal Testing Revenue by Countries
7.1 Asia-Pacific Non-Invasive Prenatal Testing Revenue by Countries (2015-2020)
7.2 China Non-Invasive Prenatal Testing Revenue and Growth Rate (2015-2020)
7.3 Japan Non-Invasive Prenatal Testing Revenue and Growth Rate (2015-2020)
7.4 Korea Non-Invasive Prenatal Testing Revenue and Growth Rate (2015-2020)
7.5 India Non-Invasive Prenatal Testing Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Non-Invasive Prenatal Testing Revenue and Growth Rate (2015-2020)
8 South America Non-Invasive Prenatal Testing Revenue by Countries
8.1 South America Non-Invasive Prenatal Testing Revenue by Countries (2015-2020)
8.2 Brazil Non-Invasive Prenatal Testing Revenue and Growth Rate (2015-2020)
8.3 Argentina Non-Invasive Prenatal Testing Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Non-Invasive Prenatal Testing by Countries
9.1 Middle East & Africa Non-Invasive Prenatal Testing Revenue by Countries (2015-2020)
9.2 Saudi Arabia Non-Invasive Prenatal Testing Revenue and Growth Rate (2015-2020)
9.3 UAE Non-Invasive Prenatal Testing Revenue and Growth Rate (2015-2020)
9.4 Egypt Non-Invasive Prenatal Testing Revenue and Growth Rate (2015-2020)
9.5 South Africa Non-Invasive Prenatal Testing Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Non-Invasive Prenatal Testing Revenue and Market Share by Type (2015-2020)
10.2 Global Non-Invasive Prenatal Testing Market Forecast by Type (2019-2024)
10.3 High & Average Risk Revenue Growth Rate (2015-2025)
10.4 Low Risk Revenue Growth Rate (2015-2025)
11 Global Non-Invasive Prenatal Testing Market Segment by Application
11.1 Global Non-Invasive Prenatal Testing Revenue Market Share by Application (2015-2020)
11.2 Non-Invasive Prenatal Testing Market Forecast by Application (2019-2024)
11.3 0-12 weeks Revenue Growth (2015-2020)
11.4 13-24 weeks Revenue Growth (2015-2020)
11.5 25-36 weeks Revenue Growth (2015-2020)
12 Global Non-Invasive Prenatal Testing Market Size Forecast (2021-2025)
12.1 Global Non-Invasive Prenatal Testing Market Size Forecast (2021-2025)
12.2 Global Non-Invasive Prenatal Testing Market Forecast by Regions (2021-2025)
12.3 North America Non-Invasive Prenatal Testing Revenue Market Forecast (2021-2025)
12.4 Europe Non-Invasive Prenatal Testing Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Non-Invasive Prenatal Testing Revenue Market Forecast (2021-2025)
12.6 South America Non-Invasive Prenatal Testing Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Non-Invasive Prenatal Testing Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables

Table 1. Global Non-Invasive Prenatal Testing Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Non-Invasive Prenatal Testing by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Non-Invasive Prenatal Testing Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Non-Invasive Prenatal Testing Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Sequenom Corporate Information, Location and Competitors
Table 6. Sequenom Non-Invasive Prenatal Testing Major Business
Table 7. Sequenom Non-Invasive Prenatal Testing Total Revenue (USD Million) (2017-2018)
Table 8. Sequenom SWOT Analysis
Table 9. Sequenom Non-Invasive Prenatal Testing Product and Solutions
Table 10. Sequenom Non-Invasive Prenatal Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Berry Genomics Corporate Information, Location and Competitors
Table 12. Berry Genomics Non-Invasive Prenatal Testing Major Business
Table 13. Berry Genomics Non-Invasive Prenatal Testing Total Revenue (USD Million) (2018-2019)
Table 14. Berry Genomics SWOT Analysis
Table 15. Berry Genomics Non-Invasive Prenatal Testing Product and Solutions
Table 16. Berry Genomics Non-Invasive Prenatal Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. LabCorp Corporate Information, Location and Competitors
Table 18. LabCorp Non-Invasive Prenatal Testing Major Business
Table 19. LabCorp Non-Invasive Prenatal Testing Total Revenue (USD Million) (2017-2018)
Table 20. LabCorp SWOT Analysis
Table 21. LabCorp Non-Invasive Prenatal Testing Product and Solutions
Table 22. LabCorp Non-Invasive Prenatal Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Roche Corporate Information, Location and Competitors
Table 24. Roche Non-Invasive Prenatal Testing Major Business
Table 25. Roche Non-Invasive Prenatal Testing Total Revenue (USD Million) (2017-2018)
Table 26. Roche SWOT Analysis
Table 27. Roche Non-Invasive Prenatal Testing Product and Solutions
Table 28. Roche Non-Invasive Prenatal Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Illumina Corporate Information, Location and Competitors
Table 30. Illumina Non-Invasive Prenatal Testing Major Business
Table 31. Illumina Non-Invasive Prenatal Testing Total Revenue (USD Million) (2017-2018)
Table 32. Illumina SWOT Analysis
Table 33. Illumina Non-Invasive Prenatal Testing Product and Solutions
Table 34. Illumina Non-Invasive Prenatal Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Natera Corporate Information, Location and Competitors
Table 36. Natera Non-Invasive Prenatal Testing Major Business
Table 37. Natera Non-Invasive Prenatal Testing Total Revenue (USD Million) (2017-2018)
Table 38. Natera SWOT Analysis
Table 39. Natera Non-Invasive Prenatal Testing Product and Solutions
Table 40. Natera Non-Invasive Prenatal Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Quest Diagnostics Corporate Information, Location and Competitors
Table 42. Quest Diagnostics Non-Invasive Prenatal Testing Major Business
Table 43. Quest Diagnostics Non-Invasive Prenatal Testing Total Revenue (USD Million) (2017-2018)
Table 44. Quest Diagnostics SWOT Analysis
Table 45. Quest Diagnostics Non-Invasive Prenatal Testing Product and Solutions
Table 46. Quest Diagnostics Non-Invasive Prenatal Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. BGI Genomics Corporate Information, Location and Competitors
Table 48. BGI Genomics Non-Invasive Prenatal Testing Major Business
Table 49. BGI Genomics Non-Invasive Prenatal Testing Total Revenue (USD Million) (2017-2018)
Table 50. BGI Genomics SWOT Analysis
Table 51. BGI Genomics Non-Invasive Prenatal Testing Product and Solutions
Table 52. BGI Genomics Non-Invasive Prenatal Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Global Non-Invasive Prenatal Testing Revenue (Million USD) by Players (2015-2020)
Table 54. Global Non-Invasive Prenatal Testing Revenue Share by Players (2015-2020)
Table 55. Global Non-Invasive Prenatal Testing Revenue (Million USD) by Regions (2015-2020)
Table 56. Global Non-Invasive Prenatal Testing Revenue Market Share by Regions (2015-2020)
Table 57. North America Non-Invasive Prenatal Testing Revenue by Countries (2015-2020)
Table 58. North America Non-Invasive Prenatal Testing Revenue Market Share by Countries (2015-2020)
Table 59. Europe Non-Invasive Prenatal Testing Revenue (Million USD) by Countries (2015-2020)
Table 60. Asia-Pacific Non-Invasive Prenatal Testing Revenue (Million USD) by Countries (2015-2020)
Table 61. South America Non-Invasive Prenatal Testing Revenue by Countries (2015-2020)
Table 62. South America Non-Invasive Prenatal Testing Revenue Market Share by Countries (2015-2020)
Table 63. Middle East and Africa Non-Invasive Prenatal Testing Revenue (Million USD) by Countries (2015-2020)
Table 64. Middle East and Africa Non-Invasive Prenatal Testing Revenue Market Share by Countries (2015-2020)
Table 65. Global Non-Invasive Prenatal Testing Revenue (Million USD) by Type (2015-2020)
Table 66. Global Non-Invasive Prenatal Testing Revenue Share by Type (2015-2020)
Table 67. Global Non-Invasive Prenatal Testing Revenue Forecast by Type (2021-2025)
Table 68. Global Non-Invasive Prenatal Testing Revenue by Application (2015-2020)
Table 69. Global Non-Invasive Prenatal Testing Revenue Share by Application (2015-2020)
Table 70. Global Non-Invasive Prenatal Testing Revenue Forecast by Application (2021-2025)
Table 71. Global Non-Invasive Prenatal Testing Revenue (Million USD) Forecast by Regions (2021-2025)

List of Figures

Figure 1. Non-Invasive Prenatal Testing Picture
Figure 2. Global Non-Invasive Prenatal Testing Revenue Market Share by Type in 2019
Figure 3. High & Average Risk Picture
Figure 4. Low Risk Picture
Figure 5. Non-Invasive Prenatal Testing Revenue Market Share by Application in 2019
Figure 6. 0-12 weeks Picture
Figure 7. 13-24 weeks Picture
Figure 8. 25-36 weeks Picture
Figure 9. Global Non-Invasive Prenatal Testing Revenue (USD Million) and Growth Rate (2015-2025)
Figure 10. North America Non-Invasive Prenatal Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Europe Non-Invasive Prenatal Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Asia-Pacific Non-Invasive Prenatal Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. South America Non-Invasive Prenatal Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Middle East and Africa Non-Invasive Prenatal Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global Non-Invasive Prenatal Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Non-Invasive Prenatal Testing Revenue Share by Players in 2019
Figure 17. Global Top 5 Players Non-Invasive Prenatal Testing Revenue Market Share in 2019
Figure 18. Global Top 10 Players Non-Invasive Prenatal Testing Revenue Market Share in 2019
Figure 19. Key Players Market Share Trend
Figure 20. Global Non-Invasive Prenatal Testing Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 21. Global Non-Invasive Prenatal Testing Revenue Market Share by Regions (2015-2020)
Figure 22. Global Non-Invasive Prenatal Testing Revenue Market Share by Regions in 2018
Figure 23. North America Non-Invasive Prenatal Testing Revenue and Growth Rate (2015-2020)
Figure 24. Europe Non-Invasive Prenatal Testing Revenue and Growth Rate (2015-2020)
Figure 25. Asia-Pacific Non-Invasive Prenatal Testing Revenue and Growth Rate (2015-2020)
Figure 26. South America Non-Invasive Prenatal Testing Revenue and Growth Rate (2015-2020)
Figure 27. Middle East and Africa Non-Invasive Prenatal Testing Revenue and Growth Rate (2015-2020)
Figure 28. North America Non-Invasive Prenatal Testing Revenue Market Share by Countries (2015-2020)
Figure 29. North America Non-Invasive Prenatal Testing Revenue Market Share by Countries in 2019
Figure 30. USA Non-Invasive Prenatal Testing Revenue and Growth Rate (2015-2020)
Figure 31. Canada Non-Invasive Prenatal Testing Revenue and Growth Rate (2015-2020)
Figure 32. Mexico Non-Invasive Prenatal Testing Revenue and Growth Rate (2015-2020)
Figure 33. Europe Non-Invasive Prenatal Testing Revenue Market Share by Countries (2015-2020)
Figure 34. Europe Non-Invasive Prenatal Testing Revenue Market Share by Countries in 2019
Figure 35. Germany Non-Invasive Prenatal Testing Revenue and Growth Rate (2015-2020)
Figure 36. UK Non-Invasive Prenatal Testing Revenue and Growth Rate (2015-2020)
Figure 37. France Non-Invasive Prenatal Testing Revenue and Growth Rate (2015-2020)
Figure 38. Russia Non-Invasive Prenatal Testing Revenue and Growth Rate (2015-2020)
Figure 39. Italy Non-Invasive Prenatal Testing Revenue and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Non-Invasive Prenatal Testing Revenue Market Share by Countries (2015-2020)
Figure 41. Asia-Pacific Non-Invasive Prenatal Testing Revenue Market Share by Countries in 2019
Figure 42. China Non-Invasive Prenatal Testing Revenue and Growth Rate (2015-2020)
Figure 43. Japan Non-Invasive Prenatal Testing Revenue and Growth Rate (2015-2020)
Figure 44. Korea Non-Invasive Prenatal Testing Revenue and Growth Rate (2015-2020)
Figure 45. India Non-Invasive Prenatal Testing Revenue and Growth Rate (2015-2020)
Figure 46. Southeast Asia Non-Invasive Prenatal Testing Revenue and Growth Rate (2015-2020)
Figure 47. South America Non-Invasive Prenatal Testing Revenue Market Share by Countries (2015-2020)
Figure 48. South America Non-Invasive Prenatal Testing Revenue Market Share by Countries in 2019
Figure 49. Brazil Non-Invasive Prenatal Testing Revenue and Growth Rate (2015-2020)
Figure 50. Argentina Non-Invasive Prenatal Testing Revenue and Growth Rate (2015-2020)
Figure 51. Middle East and Africa Non-Invasive Prenatal Testing Revenue Market Share by Countries (2015-2020)
Figure 52. Middle East and Africa Non-Invasive Prenatal Testing Revenue Market Share by Countries in 2019
Figure 53. Saudi Arabia Non-Invasive Prenatal Testing Revenue and Growth Rate (2015-2020)
Figure 54. UAE Non-Invasive Prenatal Testing Revenue and Growth Rate (2015-2020)
Figure 55. Egypt Non-Invasive Prenatal Testing Revenue and Growth Rate (2015-2020)
Figure 56. South Africa Non-Invasive Prenatal Testing Revenue and Growth Rate (2015-2020)
Figure 57. Global Non-Invasive Prenatal Testing Revenue Share by Type (2015-2020)
Figure 58. Global Non-Invasive Prenatal Testing Revenue Share by Type in 2019
Figure 59. Global Non-Invasive Prenatal Testing Market Share Forecast by Type (2021-2025)
Figure 60. Global High & Average Risk Revenue Growth Rate (2015-2020)
Figure 61. Global Low Risk Revenue Growth Rate (2015-2020)
Figure 62. Global Non-Invasive Prenatal Testing Revenue Share by Application (2015-2020)
Figure 63. Global Non-Invasive Prenatal Testing Revenue Share by Application in 2019
Figure 64. Global Non-Invasive Prenatal Testing Market Share Forecast by Application (2021-2025)
Figure 65. Global 0-12 weeks Revenue Growth Rate (2015-2020)
Figure 66. Global 13-24 weeks Revenue Growth Rate (2015-2020)
Figure 67. Global 25-36 weeks Revenue Growth Rate (2015-2020)
Figure 68. Global Non-Invasive Prenatal Testing Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 69. Global Non-Invasive Prenatal Testing Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 70. Global Non-Invasive Prenatal Testing Revenue Market Share Forecast by Regions (2021-2025)
Figure 71. North America Non-Invasive Prenatal Testing Revenue Market Forecast (2021-2025)
Figure 72. Europe Non-Invasive Prenatal Testing Revenue Market Forecast (2021-2025)
Figure 73. Asia-Pacific Non-Invasive Prenatal Testing Revenue Market Forecast (2021-2025)
Figure 74. South America Non-Invasive Prenatal Testing Revenue Market Forecast (2021-2025)
Figure 75. Middle East and Africa Non-Invasive Prenatal Testing Revenue Market Forecast (2021-2025)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
  • Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 133
    According to our LPI (LP Information) latest study, the global Enzyme-Linked Immunosorbent Assay (ELISA) market size was valued at US$ 1609.4 million in 2023. With growing demand in downstream market, the Enzyme-Linked Immunosorbent Assay (ELISA) is forecast to a readjusted size of US$ 2163.2 million by 2030 with a CAGR of 4.3% during review period. The research report highlights the growth potential of the global Enzyme-Linked Immunosorbent Assay (ELISA) market. Enzyme-Linked Immunosorb......
  • Global Microbiological Testing of Water Professional Survey Report 2023, Forecast to 2028
    Published: 26-Dec-2023        Price: US 3280 Onwards        Pages: 108
    Microbiological water testing looks for indicator organisms as a sign of faecal contamination rather than testing for specific pathogens.  Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements,......
  • Global Microbiological Testing of Water Market Research Report 2023, Forecast to 2028
    Published: 26-Dec-2023        Price: US 2680 Onwards        Pages: 167
    Microbiological water testing looks for indicator organisms as a sign of faecal contamination rather than testing for specific pathogens.  Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements,......
  • Global Companion Diagnostics Market Research Report 2024 (Status and Outlook)
    Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 129
    Report Overview: The Global Companion Diagnostics Market Size was estimated at USD 9608.10 million in 2022 and is projected to reach USD 22885.61 million by 2029, exhibiting a CAGR of 13.20% during the forecast period. This report provides a deep insight into the global Companion Diagnostics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key......
  • Global ADME-Toxicology Testing Market Research Report 2024 (Status and Outlook)
    Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 124
    Report Overview: ADME-toxicology testing is the evaluation of the metabolism of a drug molecule and its toxicity in an organism. ADME describes the pharmacological changes of a drug inside a living organism. These studies are traditionally carried out in vivo or in vitro in a controlled laboratory environment. The Global ADME-Toxicology Testing Market Size was estimated at USD 8340.90 million in 2022 and is projected to reach USD 15444.41 million by 2029, exhibiting a CAGR of 9.20% d......
  • Global Companion Diagnostics Market Research Report 2023
    Published: 14-Dec-2023        Price: US 2900 Onwards        Pages: 88
    This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Companion Diagnostics market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Roche Holdings - Abbott Laboratories - Thermo Fisher Scientific - Agilent Technologies - Life Technologies - GE Healthcare - Agendia......
  • Global Syphilis Testing Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 28-Nov-2023        Price: US 3380 Onwards        Pages: 125
    Market Overview of Global Syphilis Testing market: According to our latest research, the global Syphilis Testing market looks promising in the next 5 years. As of 2022, the global Syphilis Testing market was estimated at USD 4240.29 million, and it's anticipated to reach USD 4930.21 million in 2028, with a CAGR of 2.54% during the forecast years. A blood test for syphilis (VDRL stands for Venereal Disease Research Laboratory) that detects an antibody that is present in the bl......
  • Global Direct-to-consumer Genetic Testing Market Status and Outlook 2023-2028
    Published: 22-Nov-2023        Price: US 3160 Onwards        Pages: 144
    Direct-to-consumer genetic testing provides people access to their genetic information without necessarily involving a healthcare provider or health insurance company in the process. Dozens of companies currently offer direct-to-consumer genetic tests for a variety of purposes. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment ......
  • Global Mycotoxin Testing Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 16-Nov-2023        Price: US 3380 Onwards        Pages: 107
    Market Overview of Global Mycotoxin Testing market: According to our latest research, the global Mycotoxin Testing market looks promising in the next 5 years. As of 2022, the global Mycotoxin Testing market was estimated at USD 1043.41 million, and it's anticipated to reach USD 1544.04 million in 2028, with a CAGR of 6.75% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Mycotoxi......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs